meliterix 14 mg apvalkotās tabletes
norameda uab, lithuania - teriflunomīds - apvalkotā tablete - 14 mg
imaplix 10 mg + 20 mg + 30 mg apvalkotās tabletes
norameda uab, lithuania - apremilasts - apvalkotā tablete - 10 mg + 20 mg + 30 mg
imaplix 30 mg apvalkotās tabletes
norameda uab, lithuania - apremilasts - apvalkotā tablete - 30 mg
adepend 50 mg apvalkotās tabletes
norameda uab, lithuania - naltreksona hidrohlorīds - apvalkotā tablete - 50 mg
breso 50 mikrogrami/izsmidzinājumā deguna aerosols, suspensija
norameda uab, lithuania - mometazona furoāts - deguna aerosols, suspensija - 50 µg/izsmidzinājumā
lebsanan 1 mg/g ziede
norameda uab, lithuania - takrolims - ziede - 1 mg/g
libtayo
regeneron ireland designated activity company (dac) - cemiplimab - karcinoma, švamšā šūna - antineoplastiski līdzekļi - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.
boflox flavour
livisto int'l, s.l., spānija - marbofloxacin - tabletes - 20 mg - kaķi; suņi
boflox flavour
livisto int'l, s.l., spānija - marbofloxacin - tabletes - 80 mg - suņi
caremast vet
vetcare oy, somija - benzylpenicillinum procainum monohydricus - suspensija ievadīšanai tesmenī - 600 mg - laktējošas govis